EP2240222
Kerfi til lyfjagjafar fyrir liðagigtarsjúklinga
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.12.2008EP published:
4.4.2018EP application number:
08870751.8
EP translation filed:
2.7.2018Grant published:
15.7.2018EPO information:
European Patent Register
Max expiry date:
28.12.2028Expiry date:
28.12.2026Next due date:
31.12.2026
Title:
SYSTEMS FOR ADMINISTERING MEDICATION FOR RHEUMATOID ARTHRITIS PATIENTS
Timeline
Today
29.12.2008EP application
4.4.2018EP Publication
2.7.2018Translation submitted
15.7.2018Registration published
28.12.2026Expires
Owner
Name:
UCB Biopharma SPRLAddress:
Allée de la Recherche 60, 1070, Brussels, BE
Inventor
Name:
MORGAN, Darrell, P.Address:
Berkshire SL 1 3WE, GB
Name:
KONTORVICH, BorisAddress:
New York, NY, US
Name:
VORDENBERG, StevenAddress:
Amherst, NH, US
Name:
VICARI, JoernAddress:
New York, NY, US
Name:
FREITAG, EricAddress:
New York, NY, US
Name:
LEE, AlexAddress:
New York, NY, US
Name:
FORMOSA, DanAddress:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
10779Date:
11.1.2008Country:
US
Number:
135262Date:
18.7.2008Country:
US
Number:
192551Date:
18.9.2008Country:
US
Classification
Categories:
A61M 5/31, A61M 5/32
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 6.11.2018
Expires: 28.12.2019
Payer: Árnason Faktor
Number: 12
Paid: 7.11.2019
Expires: 28.12.2020
Payer: Árnason Faktor
Number: 13
Paid: 6.11.2020
Expires: 28.12.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.11.2021
Expires: 28.12.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 11.11.2022
Expires: 28.12.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.12.2023
Expires: 28.12.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 5.11.2024
Expires: 28.12.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 17.12.2025
Expires: 28.12.2026
Payer: Árnason Faktor ehf.